A domestic industry may never be too small so long as the commercial product is 100% American-made according to the latest Federal Circuit opinion.
In Wuhan Healthgen Biotech v. ITC, the Federal Circuit affirmed the...more
2/11/2025
/ Domestic Industry Requirement ,
Intellectual Property Protection ,
International Trade Commission (ITC) ,
Investment ,
IP Litigation ,
Life Sciences ,
Manufacturers ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Section 337